Correlation of Clinical and Biochemical Hyperandrogenism in Thai Women with Polycystic Ovary Syndrome

    February 2016 in “ Journal of Obstetrics and Gynaecology Research ”
    Pichai Leerasiri, Thanyarat Wongwananuruk, Suchada Indhavivadhana, Kitirat Techatraisak, Manee Rattanachaiyanont, Surasak Angsuwathana
    Image of study
    TLDR Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.
    The study investigated the relationship between clinical signs of excess male hormones (such as hirsutism, acne, and androgenic alopecia) and actual hormone levels in the blood in 145 Thai women with polycystic ovary syndrome (PCOS). It found that while clinical signs like hirsutism and acne did correlate with higher levels of free testosterone (FT) and total testosterone (TT), these clinical signs were not reliable indicators of elevated androgen levels in the blood. Specifically, the modified Ferriman-Gallwey score, used to assess hirsutism, had high specificity but low sensitivity for detecting high androgen levels, meaning it could miss cases of biochemical hyperandrogenism. Acne was the most common symptom, present in 56.6% of participants, and 84.8% had high serum-FT levels. The study concluded that blood tests are necessary to confirm hyperandrogenemia in women with PCOS, regardless of the presence or absence of clinical symptoms.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results

    Related Community Posts Join

    6 / 25 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Spironolactone or bicalutamide prescription

      in Treatment  4 upvotes 1 year ago
      The conversation is about someone seeking a doctor in the EU who prescribes spironolactone or bicalutamide for female pattern hair loss, as they are having difficulty finding treatment options beyond Minoxidil in Austria. They are asking for recommendations and are open to direct messages for assistance.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

    Related Research

    6 / 6 results